Compare WTS & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WTS | ELAN |
|---|---|---|
| Founded | 1874 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 11.8B |
| IPO Year | 1994 | 2018 |
| Metric | WTS | ELAN |
|---|---|---|
| Price | $319.83 | $24.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $335.00 | $27.89 |
| AVG Volume (30 Days) | 283.8K | ★ 6.2M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | ★ 17.03 | N/A |
| EPS | ★ 2.97 | 0.11 |
| Revenue | $2,438,500,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $11.17 | $8.21 |
| Revenue Next Year | $5.72 | $5.31 |
| P/E Ratio | ★ $106.23 | $215.32 |
| Revenue Growth | ★ 8.27 | 6.22 |
| 52 Week Low | $237.72 | $13.16 |
| 52 Week High | $345.17 | $27.72 |
| Indicator | WTS | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 64.27 | 58.58 |
| Support Level | $287.65 | $23.72 |
| Resistance Level | $317.99 | $25.78 |
| Average True Range (ATR) | 7.76 | 1.12 |
| MACD | 1.04 | 0.22 |
| Stochastic Oscillator | 81.47 | 70.54 |
Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, etc.; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. Its products are marketed through brands like Watts, Apex, Bradley, Nexa, and others. Geographically, the company derives its key revenue from the Americas, followed by Europe and the APMEA region.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.